Key facts
- Notable investors include Pollen Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for KIP Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for KIP Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About KIP Medical
Developer of plant-derived pharmaceuticals designed to treat patients with various pathological conditions involving dysregulation of the immune system. The company specializes in developing a novel drug to improve the therapy of dry mouth syndrome and other inflammatory conditions, enabling patients to enhance their quality of life and promote a more sustainable world.
- Sector
- Healthcare
- HQ
- Jerusalem, Israel
- Founded
- 2020
- Employees
- 2
- Website
- kip-medical.com/
- Ownership
- Privately Held (backing)
KIP Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in KIP Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on KIP Medical in its N-PORT filings yet. We sweep new filings monthly.